On December 22, 2025, the FDA approved oral Wegovy (semaglutide 25mg tablet) the first and only oral GLP-1 medication for chronic weight management
Tirzepatide is formulated as a sterile solution for subcutaneous injection containing tirzepatide as the active ingredient, along with inactive ingredients including sodium chloride, sodium phosphate dibasic heptahydrate, and water for injection
SPPS dramatically simplified the synthetic production of peptides compared to liquid phase peptide synthesis (LPPS) by allowing straightforward isolation of products with simple filtration at each step as opposed to more tedious extraction processes
However, these benefits are not permanently banked once treatment stops
Results often begin appearing within the first four to eight weeks
Ideally, keep it as close to your regular seven-day interval as possible